The GIFT Nifty futures, which is an early indicator of the Nifty50 index, were trading 0.12% higher by 26.5 points at 22,608, indicating that the domestic benchmark indices are likely to make a positive start on Friday.

On Thursday, 6 March, Domestic benchmark indices S&P BSE Sensex surged by 610 points or 0.83% and settled at 74,340, while the Nifty50 traded 0.93% higher by 207 points, settling at 22,500.

Here are some stocks that are likely to remain in focus on 7 March.

Tata Consultancy Services: The company has announced that it is strengthening its partnership with Northern Trust, which manages $17.4 trillion in assets. As a part of the partnership, the company will deploy its BaNCS Global Securities Platform to streamline custody operations across 99 markets. 

Kalpataru Projects: The company has announced securing a new order worth Rs 2,306 crore in its transmission and distribution business vertical in the international markets and building projects in India. 

Rail Vikas Nigam: The company has announced securing a contract worth Rs 156.36 crore from South Western Railway for electrification and infrastructure upgrades, highlighting the company’s role in India’s railways expansion. 

Bharat Electronics: The company has announced securing new defence orders worth Rs 577 crore, including an order for electronic warfare systems, radar upgrades, and communication solutions for submarines. 

Brigade Enterprises: The company has announced the launch of its premium residential project in Chennai called Brigade Altius. The project spans 6.5 acres with a total development area of 1.4 million square feet. 

RITES: The company has announced that it is securing a contract to survey the Hyderabad-Bengaluru and Hyderabad-Chennai high-speed rail corridors using LiDAR technology for a total consideration of Rs 27.96 crore.

Laurus Labs: The company has announced its plans to invest Rs 833 crore in its joint venture with Slovenia’s KRKA Pharma. As a part of the 49:51 ownership, KRKA will also invest Rs 867 crore into the joint venture. 

Biocon: The company’s subsidiary, Biocon Biologics, has announced a strategic partnership agreement with Civiva Inc. to expand access to and affordability of insulin aspart in the United States. 

TCPL Packaging: The company has announced the opening of a new greenfield unit in Chennai that is set to increase the company’s manufacturing capacity of paperboard cartons, which will strengthen its presence across India, improve service capabilities, and enhance logistics. 

Feeling overwhelmed by the markets? Let Unicorn Signals be your guide. Our user-friendly app simplifies complex data and provides actionable trading signals. Download the app today and trade with confidence!